Overall survival (OS) is a key clinical endpoint frequently used in oncology to measure the duration of life after a diagnosis or commencement of treatment. Specifically, it refers to the length of time from either the date of diagnosis or the start of treatment for a disease, such as cancer, that patients diagnosed with the disease are still alive. OS is often considered the gold standard for evaluating the efficacy of a new cancer treatment in clinical trials.
